Medicare Enrolled

Dr. Mir Asghar, M.D.

Rheumatology · Howell, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1255 E GRAND RIVER AVE, Howell, MI 48843
5175457400
In practice since 2006 (20 years)
NPI: 1194752543 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Asghar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Asghar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Asghar

Dr. Mir Asghar is a rheumatology specialist in Howell, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Asghar performed 4,001 Medicare services across 2,163 unique beneficiaries.

Between the years covered by Open Payments, Dr. Asghar received a total of $1,605 from 12 pharmaceutical and/or device companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Asghar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 27% volume in MI $1,605 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,001
Medicare services
Top 27% in MI for rheumatology
2,163
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~200 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,165 $84 $150
Ceftriaxone antibiotic injection
This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered.
427 $0 $8
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
409 $9 $40
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
255 $0 $20
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
219 $97 $179
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
205 $1 $10
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
164 $60 $120
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
163 $4 $30
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
135 $3 $25
SARS-CoV-2 immunoassay test
A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus.
117 $34 $100
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
78 $110 $171
Injection, methylprednisolone acetate, 40 mg 77 $6 $15
Influenza virus detection test
A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation.
73 $16 $33
Strep A rapid test
A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation.
65 $16 $25
COVID-19 amplified DNA/RNA probe detection
A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen.
55 $50 $100
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
53 $64 $150
Inhalation treatment for airway obstruction or sputum production
A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production.
51 $6 $46
New patient office visit, complex (60-74 min) 43 $145 $239
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
40 $8 $20
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
32 $9 $20
Albuterol inhalation solution, 1 mg
A unit dose of FDA-approved albuterol solution administered via durable medical equipment for inhalation.
28 $0 $3
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
26 $47 $150
Inhaled albuterol and ipratropium bromide via DME
Administration of FDA-approved albuterol and ipratropium bromide medication through durable medical equipment.
25 $0 $10
Inhaled ipratropium bromide, unit dose
Administration of FDA-approved ipratropium bromide inhalation solution via durable medical equipment in a unit dose form.
23 $0 $10
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
22 $10 $50
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
20 $23 $100
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
18 $50 $79
Ear wax removal
A procedure to remove impacted ear wax from the ear canal.
13 $33 $76
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,605
Total received (2018-2024)
Avg $321/year across 5 years
Bottom 42% in MI for rheumatology
12
Companies
88
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,605 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$800
2023
$442
2022
$302
2021
$27
2018
$34

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$325
Amgen Inc.
$172
AstraZeneca Pharmaceuticals LP
$160
GENZYME CORPORATION
$43
ANI Pharmaceuticals, Inc.
$23
UCB, Inc.
$21
PFIZER INC.
$21
GlaxoSmithKline, LLC.
$18
Exact Sciences Corporation
$17
Top 3 companies account for 82.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$571
AbbVie Inc.
$282
Amgen Inc.
$279
AstraZeneca Pharmaceuticals LP
$160
PFIZER INC.
$56
UCB, Inc.
$50
Mallinckrodt Hospital Products Inc.
$47
GlaxoSmithKline, LLC.
$44
GENZYME CORPORATION
$43
ANI Pharmaceuticals, Inc.
$36
Horizon Therapeutics plc
$20
Exact Sciences Corporation
$17
Top 3 companies account for 70.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BENLYSTA · Bimzelx · Cimzia · Cologuard Collection Kit · EVENITY · Enbrel · HUMIRA · KEVZARA · KRYSTEXXA · PAXLOVID · PURIFIED CORTROPHIN GEL · RINVOQ · SAPHNELO · SKYRIZI · TAVNEOS · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Howell?
Compare rheumatologists in the Howell area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
27
Per 100K population
13.8
County median income
$101,315
Nearest hospital
TRINITY HEALTH LIVINGSTON HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Asghar is a clinical cardiology specialist, with above-average Medicare volume (top 27% in MI), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Asghar experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Asghar performed 1,165 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Asghar receive payments from pharmaceutical companies?
Yes. Dr. Asghar received a total of $1,605 from 12 companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Asghar's costs compare to other rheumatologists in Howell?
Dr. Asghar's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Asghar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →